Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT00639496 · COMPLETED

Trial details

NCT number: NCT00639496
Sponsor: Zambon SpA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Fibrosis

Start date: 2000-03-01
Primary completion: 2003-07-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.